Literature DB >> 11168414

Mapping DNA-binding sites of HIV-1 integrase by protein footprinting.

A M Dirac1, J Kjems.   

Abstract

The HIV-1 integrase protein catalyzes integration of the viral genome into host cell DNA. Whereas the structures of the three domains of integrase have been solved separately, both the structural organization of the full-length protein and its interaction with DNA remain unresolved. A protein footprinting approach was employed to investigate the accessibility of residues in the full-length soluble integrase mutant, INF(185K,C280S), to proteolytic attack in the absence and presence of DNA. The N-terminal and C-terminal domains were relatively more accessible to proteolytic attack than the core domain. The susceptibility to proteolytic attack was specifically affected by DNA at residues Lys34, in the N-terminal domain, Lys111, Lys136, Glu138, Lys156-Lys160, Lys185-Lys188, in the core domain, and Asp207, Lys 215, Glu246, Lys258 and Lys273 in the linker and C-terminal domain, suggesting that these regions are involved in, or shielded by, DNA binding. Lys34 is positioned in a putative dimerization domain, consistent with the notion that DNA stabilizes the dimeric state of integrase.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11168414     DOI: 10.1046/j.1432-1327.2001.01932.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  13 in total

1.  Structural dynamics of native and V260E mutant C-terminal domain of HIV-1 integrase.

Authors:  Balasubramanian Sangeetha; Rajagopalan Muthukumaran; Ramaswamy Amutha
Journal:  J Comput Aided Mol Des       Date:  2015-01-14       Impact factor: 3.686

2.  A three-dimensional model of the human immunodeficiency virus type 1 integration complex.

Authors:  Jerome Wielens; Ian T Crosby; David K Chalmers
Journal:  J Comput Aided Mol Des       Date:  2005-05       Impact factor: 3.686

3.  Acetylation of HIV-1 integrase by p300 regulates viral integration.

Authors:  Anna Cereseto; Lara Manganaro; Maria Ines Gutierrez; Mariaelena Terreni; Antonio Fittipaldi; Marina Lusic; Alessandro Marcello; Mauro Giacca
Journal:  EMBO J       Date:  2005-08-11       Impact factor: 11.598

4.  Sequential deletion of the integrase (Gag-Pol) carboxyl terminus reveals distinct phenotypic classes of defective HIV-1.

Authors:  Kevin D Mohammed; Michael B Topper; Mark A Muesing
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

5.  Genetic analyses of DNA-binding mutants in the catalytic core domain of human immunodeficiency virus type 1 integrase.

Authors:  Richard Lu; Ana Limón; Hina Z Ghory; Alan Engelman
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  Genetic analyses of conserved residues in the carboxyl-terminal domain of human immunodeficiency virus type 1 integrase.

Authors:  Richard Lu; Hina Z Ghory; Alan Engelman
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

7.  Model of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug design.

Authors:  Rajeshri G Karki; Yun Tang; Terrence R Burke; Marc C Nicklaus
Journal:  J Comput Aided Mol Des       Date:  2005-06-27       Impact factor: 3.686

8.  Evaluation of the functional involvement of human immunodeficiency virus type 1 integrase in nuclear import of viral cDNA during acute infection.

Authors:  Tamako Ikeda; Hironori Nishitsuji; Xin Zhou; Nobuo Nara; Takashi Ohashi; Mari Kannagi; Takao Masuda
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

9.  Biochemical and random mutagenesis analysis of the region carrying the catalytic E152 amino acid of HIV-1 integrase.

Authors:  C Calmels; V Richard de Soultrait; A Caumont; C Desjobert; A Faure; M Fournier; L Tarrago-Litvak; V Parissi
Journal:  Nucleic Acids Res       Date:  2004-03-03       Impact factor: 16.971

10.  Specificity of LTR DNA recognition by a peptide mimicking the HIV-1 integrase {alpha}4 helix.

Authors:  Zeina Hobaika; Loussine Zargarian; Yves Boulard; Richard G Maroun; Olivier Mauffret; Serge Fermandjian
Journal:  Nucleic Acids Res       Date:  2009-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.